Interparfums, Inc. (IPAR)
(Delayed Data from NSDQ)
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Zacks News
Inter Parfums (IPAR) Benefits from Solid Brands Amid High Cost
by Zacks Equity Research
Inter Parfums (IPAR) is benefiting from continued momentum in the fragrance market and successful product launches.
Are Options Traders Betting On a Big Move In Inter Parfums (IPAR) Stock?
by Zacks Equity Research
Investors need to pay close attention to Inter Parfums (IPAR) stock based on the movements in the options market lately.
Inter Parfums (IPAR) Q1 Earnings Miss, Sales Up on Solid Brands
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2024 results reflect the resilience of the fragrance market and the strength of major brands. However, challenges in European-based operations are a downside.
Inter Parfums (IPAR) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Inter Parfums (IPAR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Inter Parfums (IPAR) Q1 Earnings Coming Up: What's in Store?
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter results are likely to reflect gains from solid brands and favorable trends in the U.S. fragrance space amid high SG&A costs and challenges in the European market.
Service Corp. (SCI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Service Corp. (SCI) delivered earnings and revenue surprises of 4.71% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Inter Parfums (IPAR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) Q1 Sales Advance on Brand Strength
by Zacks Equity Research
Inter Parfums' (IPAR) U.S.-based operations witness remarkable 18% sales growth in the first quarter, primarily driven by the Donna Karan/DKNY and GUESS products.
Inter Parfums (IPAR) Poised on Brand Strength, Expansion Efforts
by Zacks Equity Research
Inter Parfums' (IPAR) product launches, brand extension, expansion through new licenses or acquisitions and solid product demand have been aiding growth.
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Inter Parfums (IPAR) Benefits From Solid Demand Amid Cost Woes
by Zacks Equity Research
Continuous innovation in developing and marketing its range of fragrances, combined with the strength of the fragrance market, positions Inter Parfums (IPAR) well.
McCormick (MKC) Q1 Earnings Coming Up: Factors to Note
by Zacks Equity Research
McCormick's (MKC) first-quarter performance is likely to reflect the adverse impact of cost inflation. Also, rising SG&A costs are a concern.
Archer Daniels (ADM) Announces Accelerated Share Repurchases
by Zacks Equity Research
Archer Daniels (ADM) announces an accelerated share repurchase agreement to buy back $1 billion of its common stock.
Archer Daniels (ADM) Q4 Earnings Beat, Revenues Dip Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports lower y/y sales in fourth-quarter 2023 due to a decline in sales across all segments.
Monster Beverage's (MNST) Growth Strategies Progress Well
by Zacks Equity Research
Monster Beverage (MNST) has been gaining from strength in its energy drinks category and product innovations.
COTY Benefits From Solid Beauty Trends and Partnerships
by Zacks Equity Research
Coty (COTY) is well-positioned to capitalize on favorable beauty trends. The company is making several strategic partnerships to enhance its brand portfolio.
Monster Beverage (MNST) Q4 Earnings Miss, Sales Rise Y/Y
by Zacks Equity Research
Monster Beverage (MNST) posts soft fourth-quarter 2023 results, wherein the top and bottom lines miss the Zacks Consensus Estimate.
Inter Parfums (IPAR) Lags Q4 Earnings Estimate, Sales Rise Y/Y
by Zacks Equity Research
Inter Parfums (IPAR) reports fourth-quarter 2023 performance, with earnings declining year over year. Net sales increase on continued demand for its brands.
Inter Parfums (IPAR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Inter Parfums (IPAR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Freshpet (FRPT) Q4 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Freshpet's (FRPT) impressive quarterly results, along with strategic improvements and an optimistic 2024 outlook, indicate a bright future for the company.
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
by Zacks Equity Research
HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte are part of the Zacks top Analyst Blog.
Celsius Holdings (CELH) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Celsius Holdings' (CELH) fourth-quarter results are likely to reflect gains from effective distribution strategies, strong market penetration, product innovation and operational excellence.
The Zacks Analyst Blog Highlights Colgate-Palmolive, Church & Dwight, Inter Parfums, Lamb Weston and Molson Coors Beverage
by Zacks Equity Research
Colgate-Palmolive, Church & Dwight, Inter Parfums, Lamb Weston and Molson Coors Beverage are part of the Zacks top Analyst Blog.
What Will Global Partners' (GLP) Q4 Earnings Unveil?
by Zacks Equity Research
Global Partners LP (GLP) beat the Zacks Consensus Estimate for earnings in two of the last four quarters and missed in the other two.
Hormel Foods (HRL) Q1 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Hormel Foods' (HRL) fiscal first-quarter results are likely to reflect challenges in the International segment, while capacity expansion endeavors bode well.